Transcatheter Aortic Valve Replacement (TAVR) Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Transcatheter Aortic Valve Replacement (TAVR) Market Report Overview
The transcatheter aortic valve replacement (TAVR) market was valued at $8.09 billion in 2023. The market is anticipated to grow at a CAGR of more than 8% from 2023 to 2033. Transcatheter Aortic Valve Replacement (TAVR), also known as, Transcatheter Aortic Valve Implantation (TAVI), is a minimally invasive procedure used to treat severe symptomatic aortic valve stenosis. Aortic stenosis is caused by a narrowing of the aortic valve tissue, often due to calcification that builds up as a person ages. This narrowing restricts blood flow through the chambers of the heart, potentially leading to heart failure if not treated.
TAVR Market Outlook 2023-2033 ($ Billion)
Buy the Full Report for Detailed Insights on the TAVR Market Forecast,
Download a Free Sample Report
The TAVR market research report explains the market behavior, which will help identify quantitative market trends within the cardiovascular devices therapeutic area. The report has extensively covered regional-wise quantitative data, highlighting the number of TAVRs across labs, which will help in identifying untapped market opportunities. The model also discusses the detailed impact of COVID-19 on the TAVR market for 2020 and beyond.
Market Size (2023) | $8.09 billion |
CAGR (2023-2033) | >8% |
Historic Period | 2015-2023 |
Forecast Period | 2023-2033 |
Key Regions |
|
Key Companies |
|
Enquire & Decide | Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase. |
TAVR Market Dynamics
The market for TAVR procedures has witnessed tremendous growth across all geographies in recent years as more and more countries standardize the procedure, and the target population continues to grow. When first manufactured, TAVR devices were initially used in patients with severe aortic stenosis at extreme risk for surgery. Over the years, as device design has become more refined and more and more clinical trial data has supported the TAVR procedure, device indications have expanded to include additional patient populations. Devices by Edwards Lifesciences (the Sapien brand) and Medtronic plc (the CoreValve Evolut brand) have both been FDA-approved for use in intermediate- and low-risk patients. In addition, the TAVR market is growing as TAVR devices are increasingly used as an option for valve-in-valve replacement.
In recent years, there has been an upsurge in the demand for TAVR procedures for conditions with bicuspid anatomy. Moreover, positive clinical trial results (especially regarding device durability), and competition from new players will also drive the market’s growth over the forecast period.
TAVR Market Segmentation by Regions
The key regions in the TAVR market are Asia-Pacific, Europe, the Middle East and Africa, North America, and South and Central America. In 2023, North America had the largest share of the TAVR market.
TAVR Market Analysis by Regions, 2023 (%)
Buy the Full Report for More Regional Insights into the TAVR Market, Download a Free Sample Report
TAVR Market – Competitive Landscape
The key companies in the TAVR market are Edwards Lifesciences Corp, Medtronic Plc, Abbott Laboratories, Boston Scientific Corp, and MicroPort Scientific Corp among others. In 2023, Edwards Lifesciences Corp accounted for the highest TAVR market share and value.
TAVR Market Analysis by Companies, 2023 (%)
Buy the Full Report to Know More About Leading TAVR Market Players
Download a Free Sample Report
Segments Covered in this Report
TAVR Regional Outlook ($ Billion, 2015-2033)
- Asia-Pacific
- Europe
- Middle East and Africa
- North America
- South and Central America
Key Inclusions of the market model are:
Currently marketed TAVR market and evolving competitive landscape:
- Insightful review of the key industry trends.
- Annualized total TAVR market revenue by segment and market outlooks from 2015-2033.
- Market-level data on units, average selling prices, and market values.
Global, Regional, and Country level market specific insights:
- Qualitative market-specific information is available with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country-specific insights on the market.
- SWOT analysis for the TAVR market.
- Competitive dynamics insights and trends provided for the TAVR market.
Understand the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.
- Country-specific overview of the healthcare system.
- Country-specific reimbursement policies.
- Country-specific medtech regulatory landscape.
Robust methodologies and sources enable the model to provide an extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real-world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.
Companies covered: Edwards Lifesciences, Medtronic Plc, Abbott Laboratories, Boston Scientific Corp, MicroPort Scientific Corp, and others.
Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.
Scope
This Market Model gives important, expert insight you won’t find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for
- CMO executives must have a deep understanding of the TAVR marketplace to make strategic planning and investment decisions.
- Sourcing and procurement executives must understand crucial components of the supply base to make decisions about supplier selection and management.
- Private equity investors who need a deeper understanding of the market to identify and value potential investment targets.
Reasons to Buy
- Understand the impact of COVID-19 on TAVR.
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving TAVR.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the TAVR market in the future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company’s share of market leaders.
- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
- Track device sales in the global and country-specific TAVR market from 2015-2033.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.
Medtronic Plc
Abbott Laboratories
Boston Scientific Corp
MicroPort Scientific Corp
Others
Frequently asked questions
-
What was the TAVR market size in 2023?
The TAVR market size was $8.09 billion in 2023.
-
What will the CAGR for TAVR market be during 2023-2033?
The TAVR market will grow at a CAGR of more than 8% from 2033 to 2033.
-
Which region dominated the TAVR market in 2023?
North America accounted for the highest share of the TAVR market in 2023.
-
Which are the key companies operating in the TAVR market?
The key companies in the TAVR market are Edwards Lifesciences, Medtronic Plc, Abbott Laboratories, Boston Scientific Corp, MicroPort Scientific Corp, and others.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.